# MDPK67b in Patients With Prostate Cancer

> **NCT05580107** · PHASE1 · UNKNOWN · sponsor: **Med Discovery SA** · enrollment: 15 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** MDPK67b

## Key facts

- **NCT ID:** NCT05580107
- **Lead sponsor:** Med Discovery SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-09
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2023-11-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05580107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05580107, "MDPK67b in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05580107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*